Merck research division
Four senior VPs and two VPs named. Burton Christensen, PhD, moves to senior VP-chemistry; Stanley Fidelman to senior VP-basic chemistry; Marvin Jaffe, MD, to senior VP-medical affairs; and Charles Leighton, MD, to senior VP-regulatory affairs worldwide. Arthur Patchett, PhD, appointed to newly-created position of VP-exploratory chemistry and Leslie Lars Iversen, MD, promoted to VP-Neuroscience Research Center, U.K.
You may also be interested in...
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.
The UK medicines regulator has a “unique opportunity” to evaluate the systems it operates and to “do things differently", according to its long-term interim head, June Raine.
No device-related warning letters were released by the US FDA the week of 22 September.